CYP3A4-IN-5
CYP3A4-IN-5 (Compound 5p) is a potent Leishmania major pteridine reductase 1 (Lm PTR1) inhibitor (IC50=12.77 µM) . CYP3A4-IN-5 is promising for research of parasite infection[1].
Product Specifications
CAS Number
70619-09-9
UNSPSC
12352005
Target
Parasite
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Smiles
S=C(N/N=C/C1=CC=C(F)C=C1)NC2=CC=CN=C2
Molecular Formula
C13H11FN4S
Molecular Weight
274.32
References & Citations
[1]Molaei S, et al. Synthesis of thiosemicarbazone Schiff base derivatives as anti-leishmanial agents and molecular dynamics simulations insights. Sci Rep. 2025 Jul 10;15 (1) :24867.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSR030518 100 µg
Recombinant SARS-CoV-2 Spike Protein (RBD, Fc Tag)
Sign In for Pricing
View Details 
BNC683298-100 1x 100 µL
TRAF1 (TNFR-Associated Factor 1) (Lymphomatoid Papulosis Marker) (TRAF1/3298), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880680-100 1x 100 µL
Cyclin B1 (V92.1), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC473169-100 1x 100 µL
SOX2 (Embryonic Stem Cell Marker) (SOX2/3169R), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details